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A B S T R A C T
Supraventricular tachycardia (SVT) in infants may be resistant to multiple medica-
tions and cause life-threatening symptoms. Despite the known risks, catheter ablation 
may be necessary in rare cases. We present a 4-month-old 4.5 kg infant who presented 
with SVT that was resistant to all antiarrhythmic medications, including a combi-
nation of propafenone, amiodarone and propranolol at maximal doses. The infant 
underwent successful radiofrequency ablation of a posteroseptal accessory pathway. 
Despite later recurrence, medical therapy with propafenone and propranolol at stan-
dard doses resulted in complete control of the tachycardia until one year of age, when 
all medications were stopped without further recurrences.
I N T R O D U C T I O N
The most common cause of supraventricular tachycardia (SVT) in infants is an 
accessory pathway.1 The vast majority of infants with SVT are managed with an-
tiarrhythmic drugs, given the increased risk of interventional therapy and the favorable 
natural history of accessory pathways in infancy. However, there are infrequent cases 
where interventional therapy is absolutely indicated, either because of life-threatening 
tachycardia, or prior to a major cardiac operation which will make future treatment 
of the tachycardia very difficult, or will be complicated by the presence of the tachy-
cardia. We present the first case in the Greek literature of an infant who was treated 
with catheter ablation because of life-threatening SVT.
C A S E  R E P O R T
A 4-month-old 4.5 kg male infant was referred to our hospital for management 
of SVT. He presented in utero with persistent SVT which was treated with maternal 
administration of digoxin with initial control of the tachycardia. In the neonatal 
period he required multiple antiarrhythmic medications because of recurrent SVT, 
with several hospital admissions. He received, successively or in combination, pro-
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pranolol, digoxin, amiodarone and propafenone. Finally 
he was controlled with a combination of propranolol and 
propafenone. He presented to our hospital with recurrence 
of tachycardia, initially in stable condition. The tachycardia 
had a rate of 220 bpm and two different morphologies, one 
with narrow complex (Fig. 1a) and the other with left-bundle 
branch block (LBBB) (Fig. 1b). The tachycardia cycle length 
was slightly prolonged with the LBBB morphology, suggestive 
of a left-sided accessory pathway. There were retrograde P 
waves visible especially during the LBBB type of tachycardia. 
The infant had multiple recurrences which were interrupted 
only transiently with adenosine. He was loaded with esmolol 
(0.5 mg/kg), and a continuous infusion was started with titra-
tion up to 400 mcg/kg/min without success. An amiodarone 
bolus of 5 mg/kg with a drip of 0.4 mg/kg/hr was started. 
After initial control, he was switched to oral medications 
including propranolol 5 mg/kg/d, propafenone 15 mg/kg/d 
and amiodarone 15 mg/kg/d, with a plan to reduce the dose 
progressively to 5 mg/kg/d. However, 2 days later he developed 
sudden bradycardia with atrioventricular (AV) block, right 
bundle branch block (Fig. 2) and hypotension. He was treated 
successfully with cardiopulmonary resuscitation, intubation 
and intravenous administration of atropine and epinephrine. 
He developed again incessant SVT. Two-dimensional echo-
cardiogram showed very poor left ventricular function and 
significant mitral regurgitation. Therefore, it was decided to 
proceed with catheter ablation.
The procedure was performed during incessant SVT, us-
ing a 4 Fr diagnostic quadripolar catheter inserted through 
the left femoral vein and a 5 Fr mapping-ablation catheter 
inserted from the right femoral vein. After a very prolonged 
procedure (duration 8 hrs, fluoroscopy time 80 min), and 
23 applications, the tachycardia was interrupted. There was 
transient interruption of the tachycardia both at the right and 
the left posteroseptal sites (the latter accessed via a transseptal 
approach), but with recurrence of the tachycardia (Fig. 3a and 
b). Finally, a loop was made in the right atrium and the catheter 
was wedged in the coronary sinus ostium, where the tachycar-
dia was interrupted (Fig. 4a and b). The infant was transferred 
to the intensive care unit with the femoral sheaths left in place. 
FIGURE 1A. 12-lead ECG of narrow complex tachycardia.
FIGURE 3A. Ablation catheter at right posteroseptal site.
FIGURE 2. Bradycardia with AV block and right bundle branch 
block.
FIGURE 1B. 12-lead ECG of tachycardia with left-bundle 
branch block (LBBB).
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Because of nonsustained tachycardia recorded on the bedside 
monitor, he was taken back to the electrophysiology laboratory 
the next day and the tachycardia was easily reinduced. After 
another prolonged procedure (6.5 hrs, 38 applications) the 
tachycardia was again interrupted in the coronary sinus os. 
During the successful lesion, the maximum temperature was 
68ο C, but the power was only 7 watts. After this procedure, he 
was stabilized with no more episodes of SVT and was switched 
to oral medications (propafenone 15 mg/kg/d and propranolol 
2 mg/kg/d). He had a brief episode of tachycardia 10 days later. 
Because of this he was maintained on oral medications for a 
year with no further episodes. He has been off medications 
for a year with no further recurrences.
D I S C U S S I O N
Supraventricular tachycardia (SVT) in infancy is often 
difficult to control, requiring multiple medications, sometimes 
in combination. Typically the most challenging tachycardias 
are automatic, such as ectopic atrial or junctional tachycardia. 
Occasionally reciprocating tachycardias due to accessory path-
ways may also be very resistant to medications and in these 
cases interventional therapy may be necessary. The reluctance 
to submit an infant to catheter ablation may arise from 3 
areas: a) the natural history of SVT presenting in infancy, b) 
the highest risk of interventional therapy in infants and small 
children, and c) the technical problems related to small venous 
and cardiac structures and catheter sizes.
Perry et al studied the natural history of SVT due to acces-
sory pathways (APs) in infants and children and have shown 
that a large number (>90%) will have loss of AP conduction in 
the first year of life, but a third of them will have reappearance 
of tachycardia after 8 years of age.2 In the patients who present 
with tachycardia after 5 years of age, it persists in the majority 
of them during follow up. This pattern of clinical presentation 
forms the basis of the established practice of conservative 
management in the younger and more fragile patients and 
more aggressive therapy in the older ones. In addition, both 
experimental and clinical data suggest that radiofrequency 
FIGURE 4B. Termination of the tachycardia during final RF ap-
plication.
FIGURE 4A. Catheter positioned in the coronary sinus ostium 
during successful ablation.
FIGURE 3B. Ablation at left posteroseptal site through a trans-
septal puncture.
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catheter ablation may cause significant myocardial damage in 
younger patients. Saul et al have shown that radiofrequency 
(RF) lesions increased in size when performed in infant lambs, 
especially when placed in the ventricular myocardium.3 Al-
though the lesions that were performed on the AV groove did 
not increase in size, it may be difficult to stabilize the catheter 
strictly on the AV annulus in small hearts. Another source 
of concern is the coronary arterial circulation. The coronary 
arteries may be only 2-3 mm away from the endocardium in 
small hearts. There have been studies in animals and children 
showing potential risk for coronary arterial damage after RF 
applications, especially in the posteroseptal area.4 Despite 
all this information, several infants and young children have 
undergone RF ablation, usually for drug-refractory life-
threatening tachycardia. Blaufox et al have summarized the 
patient characteristics of infants who underwent RF ablation 
compared to the total population of the pediatric RF ablation 
registry.5 Infants comprised 2.2% of the patients (137 of 5960) 
in the registry. The majority of the patients had APs (67%) and 
the success rate was 87.8% compared to 90.9% in the older 
patients. The rest of the infants had ectopic atrial tachycardia 
(17%) and other diagnoses (AV node reentry, junctional, and 
ventricular tachycardia) in smaller numbers. The mortality 
rate in infants was 0.74% compared to 0.12% in older patients. 
Schafer et al studied factors related to mortality in the Pedi-
atric RF Ablation Registry.6 They concluded that mortality 
associated with pediatric RF catheter ablation is rare, but is 
more frequent when there is underlying heart disease, lower 
patient weight, greater number of RF energy applications, 
and left-sided procedures. Other single center series have 
documented the feasibility and safety of RF ablation in infants 
when necessary.7,8 A higher number of complications has been 
reported in patients <15 kg (8.0 vs 2.3%), although this did 
not reach statistical significance in a certain study.7 Successful 
ablation of a left lateral AP in a hydropic 2 kg premature infant 
has been reported.9 The important message from the above 
studies as well as from our case is that RF ablation in infants 
should be avoided when possible, but can be performed suc-
cessfully in cases with life-threatening tachycardias or serious 
complications of medical therapy. Technical problems can be 
solved in the majority of patients using smaller ablation cath-
eters and limited diagnostic catheters (an esophageal catheter 
can be used for atrial pacing and recording). Problems with 
venous structures and catheter size may be extremely difficult 
to solve however. In our patient the location of the accessory 
pathway was probably-left sided, based on the prolongation 
of the tachycardia cycle length during LBBB morphology and 
the repeated (although transient) termination of tachycardia 
when applying RF energy at the left posteroseptal area via 
transseptal approach. The more sustained success achieved 
when wedging the catheter in the coronary sinus ostium sug-
gests that the accessory pathway was related to the coronary 
venous system. However, the catheter size was larger than the 
coronary sinus and therefore it was not possible to advance it 
beyond the ostium. Apparently, there was significant damage 
to the AP, which allowed for better control with medications. 
Further changes in the structure and function of the AP with 
age may have led to long term cure. Conversely, the limitations 
of RF ablation reported in infants are not encountered in older 
children and adolescents, whereby the results are comparable 
to those observed in the adult population.10
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